HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease.

Abstract
Extracorporeal exposure of peripheral blood mononuclear cells to the photosensitizing compound 8-methoxypsoralen and ultraviolet A radiation has been shown to be effective in the treatment of several T-cell-mediated diseases, including cutaneous T-cell lymphoma and rejection after organ transplantation. We present 21 patients (10 men and 11 women) with hematological malignancies with a median age of 36 years (range, 25 to 55 years) who had received marrow grafts from sibling (n = 12) or unrelated (n = 9) donors. Six patients had acute graft-versus-host disease (GVHD) grade II to III not responding to cyclosporine A (CSA) and prednisolone when referred to extracorporeal photochemotherapy (ECP). In 15 patients, 2 to 24 months after bone marrow transplantation (BMT), extensive chronic GVHD with involvement of skin (n = 15), liver (n = 10), oral mucosa (n = 11), ocular glands (n = 6), and thrombocytopenia (n = 3) developed and was unresponsive to conventional therapy, including steroids. All patients were treated with ECP on 2 consecutive days every 2 weeks for the first 3 months and thereafter every 4 weeks until resolution of GVHD. ECP was tolerated excellently without any significant side effects. After a median of 14 cycles of ECP, acute GVHD resolved completely in 4 of 6 patients (67%) and partially in another 2 patients. Cutaneous chronic GVHD completely resolved in 12 of 15 (80%) patients. Contractures of knees and elbows due to scleroderma resolved partially. Oral mucosal ulcerations resolved in all patients. Seven of 10 patients (70%) with liver involvement had complete responses after ECP. After discontinuation of ECP, no severe infections were observed. Our findings suggest that ECP is a safe and effective adjunct therapy for both acute and extensive chronic GVHD with skin and visceral involvement and resistance to conventional therapy.
AuthorsH T Greinix, B Volc-Platzer, W Rabitsch, B Gmeinhart, C Guevara-Pineda, P Kalhs, J Krutmann, H Hönigsmann, M Ciovica, R M Knobler
JournalBlood (Blood) Vol. 92 Issue 9 Pg. 3098-104 (Nov 01 1998) ISSN: 0006-4971 [Print] United States
PMID9787144 (Publication Type: Journal Article)
CopyrightCopyright 1998 by The American Society of Hematology
Topics
  • Acute Disease
  • Adult
  • Anemia, Aplastic (therapy)
  • Bone Marrow Transplantation (adverse effects)
  • Chronic Disease
  • Female
  • Graft vs Host Disease (drug therapy, mortality)
  • Hematologic Neoplasms (therapy)
  • Humans
  • Immunosuppression Therapy (methods)
  • Infections (epidemiology)
  • Life Tables
  • Male
  • Middle Aged
  • Photopheresis
  • Skin (pathology)
  • Survival Analysis
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: